Olivia Brayer

Q: What is Olivia Brayer's success rate?

Olivia Brayer currently has a success rate of 89.43629957949767.

Q: What is the average return of Olivia Brayer's calls?

Their stock ratings have generated an average return of 40.04295072187764.

Cantor Fitzgerald | Healthcare

Olivia Brayer is an analyst from Cantor Fitzgerald specializing in the Healthcare sector. Ranked #497 out of 4658 analysts, they have issued 8 stock ratings with a success rate of 89.44% and an average return of 40.04%.

With 8 ratings to date, Olivia Brayer is beginning to establish credibility in the Healthcare sector. They have achieved a success rate of 89.44% and an average return of 40.04%, highlighting promising potential as their track record develops further.

#497

Out of 4658

Total Ratings

+89.44%

Success Rate

+40.04%

Average Return

Recent Ratings Analysis

CNTB

Buy

May 21, 2026

Target

$4.00

Current

$2.31

Performance

—

Olivia Brayer rated CNTB as Overweight on May 21, 2026, setting a price target of 4. Shares have remained stable near 2.31, leaving the 4 target still in play.

CTMX

Buy

Feb 04, 2026

Target

$10.00

Current

$3.72

Performance

-34.39%

On Feb 04, 2026, CTMX was given a Overweight rating by Olivia Brayer, with a target price of 10. Despite the Buy call, shares fell from 3.72 to 3.72, challenging the optimistic stance.

INSM

Buy

Dec 16, 2025

Target

$230.00

Current

$107.91

Performance

-46.23%

INSM received a Overweight rating from Olivia Brayer on Dec 16, 2025, aiming for 230. The rating hasn’t played out as hoped, with the stock trading 46.23% below expectations.

IKT

Buy

Dec 11, 2025

Target

$4.00

Current

$1.68

Performance

9.80%

On Dec 11, 2025, Olivia Brayer published a Overweight outlook on IKT, with a target of 4. Shares gained 9.80%, underscoring the accuracy of the bullish outlook toward 4.

VNDA

Buy

Oct 30, 2025

Target

$11.00

Current

$6.18

Performance

43.06%

Olivia Brayer on Oct 30, 2025 assigned VNDA a Overweight rating, with a price target of 11. The Buy call aligned well with market performance, producing a gain of 43.06%.

VRNA

Buy

Oct 08, 2025

Target

$100.00

Current

$106.91

Performance

—

On Oct 08, 2025, Olivia Brayer reaffirmed VRNA with a Overweight rating, targeting 100. Market indecision has kept the 100 target in a holding pattern.

GOSS

Buy

Sep 11, 2025

Target

—

Current

$0.22

Performance

-93.78%

GOSS was rated Overweight by Olivia Brayer on Sep 11, 2025, with a price objective of null. This case shows how bullish projections can fail, with the stock now below 0.2153.

UTHR

Buy

Sep 10, 2025

Target

$525.00

Current

$563.93

Performance

42.23%

On Sep 10, 2025, Olivia Brayer initiated coverage on UTHR with a Overweight rating and target of 525. The stock’s climb of 42.23% since the call highlights the foresight in the rating.

BMRN

Buy

Feb 20, 2025

Target

$90.00

Current

$50.20

Performance

-26.96%

Olivia Brayer issued a Overweight recommendation for BMRN on Feb 20, 2025, price target set at 90. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

VRTX

Buy

Feb 11, 2025

Target

$480.00

Current

$430.44

Performance

-5.44%

On Feb 11, 2025, VRTX was evaluated by Olivia Brayer, who gave a Overweight rating and target of 480. Investors saw limited payoff as shares fell short of the 480 target.

BMY

Hold

Feb 04, 2025

Target

$55.00

Current

$58.54

Performance

-0.98%

Olivia Brayer rated BMY as Neutral on Feb 04, 2025, setting a price target of 55. The Hold stance appears justified, as shares hovered around 58.54 with a -0.98% move.

GILD

Hold

Dec 11, 2024

Target

$80.00

Current

$130.69

Performance

41.47%

On Dec 11, 2024, GILD was given a Neutral rating by Olivia Brayer, with a target price of 80. The stock rallied from 130.69 to 130.69 after the Hold rating, surprising to the upside.

ALNY

Hold

Oct 11, 2024

Target

$220.00

Current

$298.48

Performance

4.98%

ALNY received a Neutral rating from Olivia Brayer on Oct 11, 2024, aiming for 220. Shares remained flat at 298.48, aligning with the neutral rating.

AMGN

Buy

Sep 27, 2024

Target

$405.00

Current

$331.57

Performance

2.76%

On Sep 27, 2024, Olivia Brayer published a Overweight outlook on AMGN, with a target of 405. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 331.57.

AUPH

Buy

Sep 16, 2024

Target

$10.00

Current

$15.90

Performance

123.00%

Olivia Brayer on Sep 16, 2024 assigned AUPH a Overweight rating, with a price target of 10. The Buy call aligned well with market performance, producing a gain of 123.00%.

REGN

Hold

Sep 16, 2024

Target

$1015.00

Current

$649.76

Performance

-43.65%

On Sep 16, 2024, Olivia Brayer reaffirmed REGN with a Neutral rating, targeting 1015. The Hold stance reflected market caution that was later justified.

MNKD

Buy

May 09, 2024

Target

$6.50

Current

$3.25

Performance

-24.59%

MNKD was rated Overweight by Olivia Brayer on May 09, 2024, with a price objective of 6.5. This case shows how bullish projections can fail, with the stock now below 3.25.

Frequency Asked Questions

Who is Olivia Brayer?

Olivia Brayer is an analyst from Cantor Fitzgerald specializing in the Healthcare sector.

What is Olivia Brayer's success rate?

Olivia Brayer currently has a success rate of +89.44%.

How many ratings has Olivia Brayer issued?

Olivia Brayer has issued 8 stock ratings so far.

What is the average return of Olivia Brayer's calls?

Their stock ratings have generated an average return of +40.04%.

What is Olivia Brayer's ranking?

Olivia Brayer is ranked #497 out of 4658 analysts.

What types of ratings does Olivia Brayer give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Olivia Brayer?

You can follow Olivia Brayer by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Olivia Brayer?

Their latest rating was a Buy on CNTB issued on 2026-05-21.